Helene Duhamel was recently diagnosed with non-small cell squamous cell lung cancer. Duhamel shares her thoughts on her ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC).

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Nuvation Bio's taletrectinib shows strong efficacy in ROS1-positive NSCLC, with a 90.1% response rate. Click here to find out ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

A rare lung cell helps stop COVID-19 from becoming deadly by calming ... The same NYU Langone team discovered in 2020 that a small fraction (less than 5%) of lung macrophages acted differently during ...

A simple finger test that can be done at home may provide an early indication of lung cancer. Lung cancer, which is diagnosed in nearly 40,000 people each year, tends to spread faster than other ...

Wang and his collaborators developed cell lines derived from patients with small cell lung cancer. When BRDT was suppressed in lung cancer cells, it significantly slowed tumor progression and ...

An independent data monitoring committee has determined that the HARMONi-6 trial for the first-line treatment of advanced squamous non-small cell lung cancer (NSCLC) has met its primary endpoint ...